Anxiety and Depressive Disorders in Adult Children Caring for
... The Memory and Behavior Problem Checklist (MBPC; Zarit, Reever, & Bach-Peterson, 1980) measures behavioral excesses and deficits in dementia patients and the caregiver's reaction to those problems. The 29 items include some of the problems most distressing to caregivers; for example, the patient's i ...
... The Memory and Behavior Problem Checklist (MBPC; Zarit, Reever, & Bach-Peterson, 1980) measures behavioral excesses and deficits in dementia patients and the caregiver's reaction to those problems. The 29 items include some of the problems most distressing to caregivers; for example, the patient's i ...
Levels of kinesin light chain and dynein intermediate
... observed in a number of neurodegenerative diseases [11]. A disruption of axoplasmic transport, an essential mechanism for maintenance of neuronal function is thought to underly the formation of these lesions in many of these diseases [13, 35]. Axoplasmic transport promotes the transport of proteins ...
... observed in a number of neurodegenerative diseases [11]. A disruption of axoplasmic transport, an essential mechanism for maintenance of neuronal function is thought to underly the formation of these lesions in many of these diseases [13, 35]. Axoplasmic transport promotes the transport of proteins ...
Evaluation and Management of Dizziness
... Steroid: dexamethasone, prednisone, methylprednisolone ...
... Steroid: dexamethasone, prednisone, methylprednisolone ...
amyloidosis awareness - Amyloidosis Support Groups
... of other common conditions. For instance, shortness of breath can be an indicator of heart disease, which is usually caused by atherosclerosis and coronary artery disease. One would not initially think of amyloidosis. Also, protein in the urine is an early sign of kidney disease, as in patients with ...
... of other common conditions. For instance, shortness of breath can be an indicator of heart disease, which is usually caused by atherosclerosis and coronary artery disease. One would not initially think of amyloidosis. Also, protein in the urine is an early sign of kidney disease, as in patients with ...
Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher
... Cambridge CB2 1EW, United Kingdom ...
... Cambridge CB2 1EW, United Kingdom ...
mTOR pathway – novel modulator of astrocyte activity.
... of mTOR activity disrupts brain functions and the use of a mTOR inhibitor may be involved into prevention of epileptic changes. Tuberous sclerosis complex and epilepsy Tuberous sclerosis complex (TSC) is a multiorgan disorder, mainly caused by mutations in TSC1 and TSC2, characterized by the presenc ...
... of mTOR activity disrupts brain functions and the use of a mTOR inhibitor may be involved into prevention of epileptic changes. Tuberous sclerosis complex and epilepsy Tuberous sclerosis complex (TSC) is a multiorgan disorder, mainly caused by mutations in TSC1 and TSC2, characterized by the presenc ...
Alzheimer's disease
Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.